Immune responses in mesenteric lymph nodes improve understanding of Crohn’s disease

Crohn’s disease is a chronic inflammatory bowel disease that is sometimes insufficiently controlled by immunosuppressive therapies with a subsequent need for surgical removal of affected bowel segments.

Formycon AG (von First Berlin Equity Research GmbH) – Biotech Investments

Original-Research: Formycon AG – from First Berlin Equity Research GmbH 01.10.2024 / 17:05 CET/CESTDissemination of a Research, transmitted by EQS News – a service of

October 2, 2024

Serious Syphilitic Uveitis Cases Almost Tripled Over 10-Year Period

Syphilitic uveitis cases requiring hospitalization increased from 2010 to 2019 in the U.S., amid a national shortage of the standard-of-care injectable penicillin G, according to

November 23, 2023

Denali teases early data for enzyme replacement therapy in rare disease

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.